Sino Biopharmaceutical | 1177 - Fremdkapital





Fremdkapital Veränderung Datum
Akebia Therapeutics USD 24.75M 11.64M 2026-06
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Avita Medical AUD 42.24M 1.25M 2024-12
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Dianthus Therapeutics USD 0 0 2024-12
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
IQVIA Holdings USD 13.7B 284M 2026-06
Jiangsu Hengrui CNY 38.23M 1.13M 2026-06
Moderna USD 597M 6M 2026-06
Organon & Co USD 8.48B 74M 2026-06
Revvity USD 2.63B 1.02M 2026-06
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Tectonic Therapeutic USD 17K 26K 2026-03
Viatris USD 11.61B 801.1M 2026-06
Xeris Pharmaceuticals USD 188.81M 32.42M 2026-06